Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

1.

The predictive role of atherogenic dyslipidemia in subjects with non-coronary atherosclerosis.

Berneis K, Rizzo M, Spinas GA, Di Lorenzo G, Di Fede G, Pepe I, Pernice V, Rini GB.

Clin Chim Acta. 2009 Aug;406(1-2):36-40. doi: 10.1016/j.cca.2009.05.002. Epub 2009 May 9.

PMID:
19433079
2.

Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome.

Rizzo M, Pernice V, Frasheri A, Di Lorenzo G, Rini GB, Spinas GA, Berneis K.

Clin Endocrinol (Oxf). 2009 Jun;70(6):870-5. doi: 10.1111/j.1365-2265.2008.03407.x. Epub 2008 Sep 2.

PMID:
18771560
3.

HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.

Oravec S, Dostal E, Dukát A, Gavorník P, Kucera M, Gruber K.

Neuro Endocrinol Lett. 2011;32(4):502-9.

PMID:
21876506
4.

Small, dense low-density-lipoproteins and the metabolic syndrome.

Rizzo M, Berneis K.

Diabetes Metab Res Rev. 2007 Jan;23(1):14-20. Review.

PMID:
17080469
5.

Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention?

Rizzo M, Berneis K.

J Atheroscler Thromb. 2005;12(5):237-9. Review.

6.

Interaction of family history of atherosclerosis with atherogenic lipid traits in men with non-coronary atherosclerosis.

Sentí M, Pedro-Botet J, Pavesi M, Marrugat J, Aubó C, Pena A, Martín S, Rubiés-Prat J.

Clin Chim Acta. 1997 Aug 29;264(2):193-205.

PMID:
9293377
7.

Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.

Hajer GR, van der Graaf Y, Bots ML, Algra A, Visseren FL; SMART Study Group.

Eur J Clin Invest. 2009 Aug;39(8):680-8. doi: 10.1111/j.1365-2362.2009.02155.x. Epub 2009 May 12.

PMID:
19453647
8.

Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.

Berneis K, Rizzo M, Hersberger M, Rini GB, Di Fede G, Pepe I, Spinas GA, Carmina E.

Int J Clin Pract. 2009 Jan;63(1):56-62. doi: 10.1111/j.1742-1241.2008.01897.x.

PMID:
19125993
9.

Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.

Rizzo M, Berneis K, Hersberger M, Pepe I, Di Fede G, Rini GB, Spinas GA, Carmina E.

Hum Reprod. 2009 Sep;24(9):2286-92. doi: 10.1093/humrep/dep121. Epub 2009 May 19.

PMID:
19454589
10.

Family history, diabetes and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: A one-year follow-up study.

Rizzo M, Barbagallo CM, Noto D, Pace A, Cefalú AB, Pernice V, Pinto V, Rubino A, Pieri D, Traina M, Frasheri A, Notarbartolo A, Averna MR.

Nutr Metab Cardiovasc Dis. 2005 Oct;15(5):361-7. Epub 2005 Jul 1.

PMID:
16216722
11.

Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes.

Rizzo M, Berneis K, Altinova AE, Toruner FB, Akturk M, Ayvaz G, Rini GB, Spinas GA, Arslan M.

Diabet Med. 2008 Dec;25(12):1406-11. doi: 10.1111/j.1464-5491.2008.02613.x.

PMID:
19046238
12.

Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease.

Rizzo M, Pernice V, Frasheri A, Berneis K.

Atherosclerosis. 2008 Mar;197(1):237-41. Epub 2007 May 7.

PMID:
17485096
13.

LDL size and subclasses in patients with abdominal aortic aneurysm.

Rizzo M, Krayenbühl PA, Pernice V, Frasheri A, Battista Rini G, Berneis K.

Int J Cardiol. 2009 May 29;134(3):406-8. doi: 10.1016/j.ijcard.2007.12.082. Epub 2008 Mar 25.

14.

Low-density-lipoprotein peak particle size in a Mediterranean population.

Rizzo M, Barbagallo CM, Severino M, Polizzi F, Onorato F, Noto D, Cefalù AB, Pace A, Marino G, Notarbartolo A, Averna RM.

Eur J Clin Invest. 2003 Feb;33(2):126-33.

PMID:
12588286
15.

Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease.

Miller M, Ginsberg HN, Schaefer EJ.

Am J Cardiol. 2008 Apr 1;101(7):1003-8. doi: 10.1016/j.amjcard.2007.11.046. Review.

PMID:
18359322
16.

How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?

Rizzo M, Berneis K, Carmina E, Rini GB.

Am J Obstet Gynecol. 2008 Jan;198(1):28.e1-5. doi: 10.1016/j.ajog.2007.09.014. Review.

PMID:
18166299
17.

The significance of low-density-lipoproteins size in vascular diseases.

Rizzo M, Berneis K, Corrado E, Novo S.

Int Angiol. 2006 Mar;25(1):4-9. Review.

18.

Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis.

Rizzo M, Spinas GA, Cesur M, Ozbalkan Z, Rini GB, Berneis K.

Atherosclerosis. 2009 Dec;207(2):502-6. doi: 10.1016/j.atherosclerosis.2009.07.015. Epub 2009 Jul 8.

PMID:
19643412
19.

Carotid and peripheral atherosclerosis in patients who underwent primary percutaneous coronary intervention and outcome associated with multifocal atherosclerosis.

Romano G, Corrado E, Muratori I, Novo G, Andolina G, Cospite V, Evola S, Ciaramitaro GF, Di Vincenzo A, Farinella M, Rotolo A, Assennato P, Hoffmann E, Novo S.

Int Angiol. 2006 Dec;25(4):389-94.

PMID:
17164746
20.

The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis.

Rizzo M, Corrado E, Coppola G, Muratori I, Mezzani A, Novo G, Novo S.

Intern Med J. 2009 Aug;39(8):539-45. doi: 10.1111/j.1445-5994.2009.01955.x. Epub 2009 Mar 23.

PMID:
19323703

Supplemental Content

Support Center